Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    2.

    Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models.

    Cameron N, Cotter M, Inkster M, Nangle M.

    Diabetes Res Clin Pract. 2003 Jul;61 Suppl 1:S35-9. Review.PMID: 12880693 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats.

    Keegan A, Cotter MA, Cameron NE.

    Diabetologia. 1999 Mar;42(3):343-50.PMID: 10096788 [PubMed - indexed for MEDLINE]Related articles

    4.

    Protein kinase C beta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice.

    Nangle MR, Cotter MA, Cameron NE.

    Eur J Pharmacol. 2003 Aug 15;475(1-3):99-106.PMID: 12954365 [PubMed - indexed for MEDLINE]Related articles

    5.

    The calpain inhibitor, A-705253, corrects penile nitrergic nerve dysfunction in diabetic mice.

    Nangle MR, Cotter MA, Cameron NE.

    Eur J Pharmacol. 2006 May 24;538(1-3):148-53. Epub 2006 Apr 5.PMID: 16650403 [PubMed - indexed for MEDLINE]Related articles

    6.

    IkappaB kinase 2 inhibition corrects defective nitrergic erectile mechanisms in diabetic mouse corpus cavernosum.

    Nangle MR, Cotter MA, Cameron NE.

    Urology. 2006 Jul;68(1):214-8. Epub 2006 Jun 27.PMID: 16806421 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of chelator treatment on aorta and corpus cavernosum from diabetic rats.

    Keegan A, Cotter MA, Cameron NE.

    Free Radic Biol Med. 1999 Sep;27(5-6):536-43.PMID: 10490273 [PubMed - indexed for MEDLINE]Related articles

    8.

    A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid.

    Stalker TJ, Lefer AM, Scalia R.

    Br J Pharmacol. 2001 Jun;133(3):406-12.PMID: 11375257 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice.

    Nangle MR, Cotter MA, Cameron NE.

    Eur J Pharmacol. 2004 Oct 11;502(1-2):143-8.PMID: 15464100 [PubMed - indexed for MEDLINE]Related articles

    10.

    Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.

    Ii M, Nishimura H, Kusano KF, Qin G, Yoon YS, Wecker A, Asahara T, Losordo DW.

    Circulation. 2005 Jul 5;112(1):93-102. Epub 2005 Jun 27.PMID: 15983249 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Corpus cavernosum dysfunction in diabetic rats: effects of combined alpha-lipoic acid and gamma-linolenic acid treatment.

    Keegan A, Cotter MA, Cameron NE.

    Diabetes Metab Res Rev. 2001 Sep-Oct;17(5):380-6.PMID: 11747143 [PubMed - indexed for MEDLINE]Related articles

    12.

    Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.

    Schäfer A, Fraccarollo D, Vogt C, Flierl U, Hemberger M, Tas P, Ertl G, Bauersachs J.

    Biochem Pharmacol. 2007 May 1;73(9):1367-75. Epub 2007 Jan 10.PMID: 17270148 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of diabetes and evening primrose oil treatment on responses of aorta, corpus cavernosum and mesenteric vasculature in rats.

    Jack AM, Keegan A, Cotter MA, Cameron NE.

    Life Sci. 2002 Sep 6;71(16):1863-77.PMID: 12175702 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of aldose reductase inhibition on responses of the corpus cavernosum and mesenteric vascular bed of diabetic rats.

    Keegan A, Jack AM, Cotter MA, Cameron NE.

    J Cardiovasc Pharmacol. 2000 Apr;35(4):606-13.PMID: 10774792 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.

    Laufs U, Gertz K, Dirnagl U, Böhm M, Nickenig G, Endres M.

    Brain Res. 2002 Jun 28;942(1-2):23-30.PMID: 12031849 [PubMed - indexed for MEDLINE]Related articles

    16.

    Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor.

    Jones SP, Gibson MF, Rimmer DM 3rd, Gibson TM, Sharp BR, Lefer DJ.

    J Am Coll Cardiol. 2002 Sep 18;40(6):1172-8.PMID: 12354446 [PubMed - indexed for MEDLINE]Related articles

    17.

    Correction of nitrergic neurovascular dysfunction in diabetic mouse corpus cavernosum by p38 mitogen-activated protein kinase inhibition.

    Nangle MR, Cotter MA, Cameron NE.

    Int J Impot Res. 2006 May-Jun;18(3):258-63.PMID: 16355109 [PubMed - indexed for MEDLINE]Related articles

    18.

    Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.

    Schäfer A, Fraccarollo D, Eigenthaler M, Tas P, Firnschild A, Frantz S, Ertl G, Bauersachs J.

    Arterioscler Thromb Vasc Biol. 2005 May;25(5):1071-7. Epub 2005 Mar 10.PMID: 15761193 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo.

    Pelat M, Dessy C, Massion P, Desager JP, Feron O, Balligand JL.

    Circulation. 2003 May 20;107(19):2480-6. Epub 2003 Apr 28.PMID: 12719275 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum.

    Paskaloglu K, Sener G, Ayanğolu-Dülger G.

    Eur J Pharmacol. 2004 Sep 24;499(3):345-54.PMID: 15381057 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data